Ramipril
Ramipril is a pharmaceutical drug with 96 clinical trials. Currently 5 active trials ongoing. Historical success rate of 84.8%.
Success Metrics
Based on 67 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
17
Mid Stage
63
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.8%
67 of 80 finished
16.3%
13 ended early
5
trials recruiting
96
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
Bariatric Surgery and Pharmacokinetics of Ramipril
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
Clinical Trials (96)
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
Bariatric Surgery and Pharmacokinetics of Ramipril
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
Doxazosin and Ramipril in Hypertension
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction
Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD
Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction
A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril
Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab
Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial
Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)
Ramipril in Pediatric Patients on Hemodialysis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 96